Document is current

Any future updates will be listed below

Correction: An Open‑Label Extension Study Assessing the Long‑Term Safety and Efficacy of Viloxazine Extended‑Release Capsules in Adults with Attention‑Deficit/Hyperactivity Disorder

Crossref DOI link: https://doi.org/10.1007/s40263-026-01285-w

Published Online: 2026-03-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark